• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑瘤因子调节 T 细胞分化和抗肿瘤疗效。

The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy.

机构信息

Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.

Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Front Immunol. 2024 Apr 16;15:1293723. doi: 10.3389/fimmu.2024.1293723. eCollection 2024.

DOI:10.3389/fimmu.2024.1293723
PMID:38690263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11058823/
Abstract

T cells must adapt to variations in tissue microenvironments; these adaptations include the degree of oxygen availability. The hypoxia-inducible factor (HIF) transcription factors control much of this adaptation, and thus regulate many aspects of T cell activation and function. The HIFs are in turn regulated by oxygen-dependent hydroxylases: both the prolyl hydroxylases (PHDs) which interact with the VHL tumour suppressor and control HIF turnover, and the asparaginyl hydroxylase known as the Factor inhibiting HIF (FIH), which modulates HIF transcriptional activity. To determine the role of this latter factor in T cell function, we generated T cell-specific FIH knockout mice. We found that FIH regulates T cell fate and function in a HIF-dependent manner and show that the effects of FIH activity occur predominantly at physiological oxygen concentrations. T cell-specific loss of FIH boosts T cell cytotoxicity, augments T cell expansion , and improves anti-tumour immunotherapy in mice. Specifically inhibiting FIH in T cells may therefore represent a promising strategy for cancer immunotherapy.

摘要

T 细胞必须适应组织微环境的变化;这些适应包括氧气供应的程度。缺氧诱导因子 (HIF) 转录因子控制着这种适应的大部分,从而调节 T 细胞激活和功能的许多方面。HIFs 反过来又受到氧依赖性羟化酶的调节:与 VHL 肿瘤抑制因子相互作用并控制 HIF 周转率的脯氨酰羟化酶 (PHD),以及调节 HIF 转录活性的天冬酰胺羟化酶,称为 HIF 抑制因子 (FIH)。为了确定后者在 T 细胞功能中的作用,我们生成了 T 细胞特异性 FIH 敲除小鼠。我们发现 FIH 以 HIF 依赖的方式调节 T 细胞命运和功能,并表明 FIH 活性的影响主要发生在生理氧浓度下。T 细胞特异性缺失 FIH 可增强 T 细胞的细胞毒性,增强 T 细胞扩增,并改善小鼠的抗肿瘤免疫治疗。因此,特异性抑制 T 细胞中的 FIH 可能代表癌症免疫治疗的一种有前途的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/c70efd689312/fimmu-15-1293723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/74f9b3cd7bab/fimmu-15-1293723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/289034a61c53/fimmu-15-1293723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/16e4b288f229/fimmu-15-1293723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/c70efd689312/fimmu-15-1293723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/74f9b3cd7bab/fimmu-15-1293723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/289034a61c53/fimmu-15-1293723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/16e4b288f229/fimmu-15-1293723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1b6/11058823/c70efd689312/fimmu-15-1293723-g004.jpg

相似文献

1
The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy.抑瘤因子调节 T 细胞分化和抗肿瘤疗效。
Front Immunol. 2024 Apr 16;15:1293723. doi: 10.3389/fimmu.2024.1293723. eCollection 2024.
2
Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.抑制缺氧诱导因子(FIH)作为氧传感器作用的动力学研究。
J Biol Chem. 2015 Aug 7;290(32):19726-42. doi: 10.1074/jbc.M115.653014. Epub 2015 Jun 25.
3
Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.天冬酰胺酰羟化酶(FIH)在氧感应途径中的催化特性与其脯氨酰4-羟化酶不同。
J Biol Chem. 2004 Mar 12;279(11):9899-904. doi: 10.1074/jbc.M312254200. Epub 2003 Dec 29.
4
Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.口疮病毒的锚蛋白重复序列蛋白影响细胞缺氧反应途径。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01430-16. Print 2017 Jan 1.
5
Deletion of the gene encoding an inhibitor of hypoxia-inducible factors increases hypoxia tolerance in zebrafish.删除编码缺氧诱导因子抑制剂的基因可提高斑马鱼的耐缺氧能力。
J Biol Chem. 2018 Oct 5;293(40):15370-15380. doi: 10.1074/jbc.RA118.003004. Epub 2018 Aug 20.
6
Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease.慢性肾脏病中缺氧和缺氧诱导因子 asparaginyl 羟化酶调节的演变。
Nephrol Dial Transplant. 2023 Sep 29;38(10):2276-2288. doi: 10.1093/ndt/gfad075.
7
Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.抑制氧感知天冬酰胺羟化酶因子抑制低氧诱导因子:一种潜在的缺氧反应调节策略。
J Med Chem. 2021 Jun 10;64(11):7189-7209. doi: 10.1021/acs.jmedchem.1c00415. Epub 2021 May 24.
8
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected].天冬酰胺基羟化酶因子抑制缺氧诱导因子(FIH)在调节缺氧诱导因子(HIF)转录靶基因中的作用的遗传分析[校正后]
J Biol Chem. 2004 Oct 8;279(41):42719-25. doi: 10.1074/jbc.M406713200. Epub 2004 Aug 9.
9
Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?缺氧诱导因子 (HIF) 羟化酶介导的蛋白质羟化:独特还是普遍存在?
Cells. 2019 Apr 26;8(5):384. doi: 10.3390/cells8050384.
10
Knockout of Factor-Inhibiting HIF () in Colon Epithelium Attenuates Chronic Colitis but Does Not Reduce Colorectal Cancer in Mice.敲除结肠上皮细胞中的因子抑制 HIF()可减轻慢性结肠炎,但不能减少小鼠结直肠癌的发生。
J Immunol. 2022 Mar 1;208(5):1280-1291. doi: 10.4049/jimmunol.2100418. Epub 2022 Feb 4.

引用本文的文献

1
HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses.缺氧诱导因子脯氨酰羟化酶抑制剂在T细胞中诱导假性缺氧,并通过增强抗肿瘤免疫反应抑制微卫星稳定型结直肠癌的生长。
Cancer Immunol Immunother. 2025 May 9;74(7):192. doi: 10.1007/s00262-025-04067-3.

本文引用的文献

1
Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy.激活时的氧气水平决定了 T 细胞的持久性和免疫治疗效果。
Elife. 2023 May 11;12:e84280. doi: 10.7554/eLife.84280.
2
Vitamin B6 Metabolism Determines T Cell Anti-Tumor Responses.维生素 B6 代谢决定 T 细胞抗肿瘤反应。
Front Immunol. 2022 Feb 17;13:837669. doi: 10.3389/fimmu.2022.837669. eCollection 2022.
3
Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.缺氧诱导因子活性通过 CD8+T 细胞促进抗肿瘤效应功能和组织驻留。
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI143729.
4
Modified Hypoxia-Inducible Factor Expression in CD8 T Cells Increases Antitumor Efficacy.CD8 T 细胞中缺氧诱导因子表达的修饰可增强抗肿瘤疗效。
Cancer Immunol Res. 2021 Apr;9(4):401-414. doi: 10.1158/2326-6066.CIR-20-0561. Epub 2021 Feb 18.
5
Mechanisms of hypoxia signalling: new implications for nephrology.缺氧信号转导机制:对肾脏病学的新启示。
Nat Rev Nephrol. 2019 Oct;15(10):641-659. doi: 10.1038/s41581-019-0182-z. Epub 2019 Sep 5.
6
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.罗沙司他治疗长期透析患者的贫血。
N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24.
7
Hypoxia induces rapid changes to histone methylation and reprograms chromatin.缺氧诱导组蛋白甲基化的快速变化,并重新编程染色质。
Science. 2019 Mar 15;363(6432):1222-1226. doi: 10.1126/science.aau5870. Epub 2019 Mar 14.
8
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate.组蛋白去甲基化酶 KDM6A 直接感知氧气以控制染色质和细胞命运。
Science. 2019 Mar 15;363(6432):1217-1222. doi: 10.1126/science.aaw1026. Epub 2019 Mar 14.
9
The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia.抑瘤素 M 调节缺氧诱导因子脯氨酰羟化酶活性对低氧代谢重编程的作用及其机制研究
Cell Metab. 2018 Apr 3;27(4):898-913.e7. doi: 10.1016/j.cmet.2018.02.020.
10
Mitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions.线粒体与缺氧:细胞命运决策中的代谢串扰
Trends Endocrinol Metab. 2018 Apr;29(4):249-259. doi: 10.1016/j.tem.2018.02.002. Epub 2018 Feb 28.